Xencor (FRA:XE9) Days Sales Outstanding : 74.23 (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Xencor Days Sales Outstanding?

Xencor's average Accounts Receivable for the three months ended in Mar. 2024 was €9.6 Mil. Xencor's Revenue for the three months ended in Mar. 2024 was €11.8 Mil. Hence, Xencor's Days Sales Outstanding for the three months ended in Mar. 2024 was 74.23.

The historical rank and industry rank for Xencor's Days Sales Outstanding or its related term are showing as below:

FRA:XE9' s Days Sales Outstanding Range Over the Past 10 Years
Min: 14.5 Med: 46.4 Max: 105.77
Current: 52.1

During the past 13 years, Xencor's highest Days Sales Outstanding was 105.77. The lowest was 14.50. And the median was 46.40.

FRA:XE9's Days Sales Outstanding is ranked better than
67.91% of 888 companies
in the Biotechnology industry
Industry Median: 72.34 vs FRA:XE9: 52.10

Xencor's Days Sales Outstanding declined from Mar. 2023 (118.30) to Mar. 2024 (74.23).

Xencor Days Sales Outstanding Historical Data

The historical data trend for Xencor's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xencor Days Sales Outstanding Chart

Xencor Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

36.71

52.16

51.09

101.17

44.60

Xencor Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															118.30	40.21	57.62	68.90	74.23

Competitive Comparison of Xencor's Days Sales Outstanding

For the Biotechnology subindustry, Xencor's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xencor's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xencor's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Xencor's Days Sales Outstanding falls into.

Xencor Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Xencor's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (27.373	+	10.353)	/	2 )	/	154.366	*	365
=	18.863					/	154.366	*	365
=	44.60

Xencor's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (10.353	+	8.814)	/	2 )	/	11.781	*	365 / 4
=	9.5835					/	11.781	*	365 / 4
=	74.23

Xencor (FRA:XE9) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Xencor Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Xencor's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Xencor (FRA:XE9) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xencor Inc (FRA:XE9) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

XNCR:USA

Address

111 West Lemon Avenue, Monrovia, CA, USA, 91016

Website

http://www.xencor.com

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

Xencor (FRA:XE9) Headlines

No Headlines